Actively Recruiting
Treatment of Central Airway Stenoses Using Computer-Assisted Customized 3d Stents TATUM
Led by University Hospital, Toulouse · Updated on 2024-11-01
30
Participants Needed
1
Research Sites
232 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Airway stenting is usually efficient to treat central airway obstruction but can lead to severe and potentially lethal complications (stent migration, obstructive granuloma, perforation, and hemoptysis). 3D customized airway stents (computer-aided conception using CT-scan data), perfectly suited to airway anatomy, should improve the tolerance and safety of airway stenting. We demonstrated in a previous pilot study, dedicated to patients with anatomically complex stenoses the safety of 3D patient-specific stents. These appealing results in highly complex situations suggest the need to evaluate these devices in more common situations. In this study we aim to test our new generation stents in all patients planned for airway stenting. After computer-assisted segmentation of airways (VGStudioMAX 3.0 software), the stenosis is virtually corrected, leading to the conception of a virtual stent (AnatomikModeling, Toulouse), allowing for the fabrication of a mold using a 3D printer. The stent is then built and sterilized (NOVATECH, Berlin) and inserted during rigid bronchoscopy. Close follow up is then conducted, including clinical evaluation after one week, three, six and 12 months; spirometry at one week, 3 months, 6 months and 12 months and chest CT-scan at one week.
CONDITIONS
Official Title
Treatment of Central Airway Stenoses Using Computer-Assisted Customized 3d Stents TATUM
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age >18 years
- Informed consent
- Complex, proximal and symptomatic airway stenosis causing symptoms such as dyspnea, cough, peak flow < 50%, FEV1 < 50%, or post-stenotic infection
You will not qualify if you...
- Acute respiratory distress or mechanical ventilation
- Contraindication to rigid bronchoscopy such as severe and irreversible coagulation disorders
- Pregnancy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University Hospital Toulouse
Toulouse, Toulouse, France, 31000
Actively Recruiting
Research Team
N
Nicolas GUIBERT, MCU-PH
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here